| Autor: |
Shipra Gupta, Ritin Mohindra, Mohita Singla, Sagar Khera, Amit Kumar, Nilminie Rathnayake, Timo Sorsa, Andreas Pfützner, Ismo T. Räisänen, Roop K. Soni, Poonam Kanta, Akanksha Jain, Krishan Gauba, Kapil Goyal, Mini P. Singh, Arnab Ghosh, Kamal Kajal, Varun Mahajan, Vikas Suri, Ashish Bhalla |
| Jazyk: |
angličtina |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Clinical and Experimental Dental Research, Vol 8, Iss 4, Pp 988-1001 (2022) |
| Druh dokumentu: |
article |
| ISSN: |
2057-4347 |
| DOI: |
10.1002/cre2.589 |
| Popis: |
Abstract Objectives The aim of this study was to validate an active matrix metalloproteinase (MMP‐8) point‐of‐care diagnostic tool in COVID‐19 patients with periodontal disease. Subjects, Materials, and Methods Seventy‐two COVID‐19‐positive and 30 COVID‐19‐negative subjects were enrolled in the study. Demographic data were recorded, periodontal examination carried out, and chairside tests run for evaluating the expression of active MMP‐8 (aMMP‐8) in the site with maximum periodontal breakdown via gingival crevicular fluid sampling as well as via a mouth rinse‐based kit for general disease activity. In COVID‐19‐positive patients, the kits were run again once the patients turned COVID‐19 negative. Results The overall (n = 102) sensitivity/specificity of the mouthrinse‐based kits to detect periodontal disease was 79.41%/36.76% and that of site‐specific kits was 64.71%/55.88% while adjusting for age, gender, and smoking status increased the sensitivity and specificity (82.35%/76.47% and 73.53%/88.24, respectively). Receiver operating characteristic (ROC) analysis for the adjusted model revealed very good area under the ROC curve 0.746–0.869 (p |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
Plný text